InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: lousy engineer post# 125570

Tuesday, 10/13/2015 10:07:38 AM

Tuesday, October 13, 2015 10:07:38 AM

Post# of 403047
Biopharma Things I have learned are pointless and fluff in PRs

Trial progression, just tell us when it's done.
Trial completion, just give us the data.
Top line data, just give us the bottom line data.
Bottom line data, you already reported some of this.
Advancement toward next phase, just tell us when it starts.
Trial start, but the completion is so far away it's meaningless.
New drug development, just tell us when it's ready for trials
INDA filing, just tell us when the trial proposal is effective
IND effective, who cares just tell us the start.
FDA designations such as QIDP, just tell us when you know more details.
Detailed decision on designation such as QIDP, we already knew most of that.
Any other trial information, so what, how much longer to approval or partnership.
Billion dollar partnership deal resulting in a price spike, now you're talking! Now I can cash out.
Market approval, who cares, I cashed out a long time ago.

Cancer Survivor, Daisy, Started Middle-School This Term

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News